Fernandez-Mateos, Javier https://orcid.org/0000-0002-4949-4131
Cresswell, George D. https://orcid.org/0000-0003-3303-068X
Trahearn, Nicholas https://orcid.org/0000-0002-8596-0996
Webb, Katharine
Sakr, Chirine
Lampis, Andrea
Stuttle, Christine
Corbishley, Catherine M.
Stavrinides, Vasilis
Zapata, Luis
Spiteri, Inmaculada https://orcid.org/0000-0002-1097-8972
Heide, Timon https://orcid.org/0000-0002-1386-7469
Gallagher, Lewis
James, Chela https://orcid.org/0000-0003-3996-0909
Ramazzotti, Daniele https://orcid.org/0000-0002-6087-2666
Gao, Annie
Kote-Jarai, Zsofia https://orcid.org/0000-0002-6329-5155
Acar, Ahmet https://orcid.org/0000-0002-2478-8029
Truelove, Lesley
Proszek, Paula https://orcid.org/0000-0002-0780-6790
Murray, Julia
Reid, Alison
Wilkins, Anna
Hubank, Michael
Eeles, Ros https://orcid.org/0000-0002-3698-6241
Dearnaley, David https://orcid.org/0000-0002-3954-2806
Sottoriva, Andrea https://orcid.org/0000-0001-6709-9533
Article History
Received: 13 September 2023
Accepted: 23 May 2024
First Online: 12 July 2024
Competing interests
: D.D.’s previous employer, the Institute of Cancer Research, receives royalty income from abiraterone. D.D. receives a share of this income through the Institute of Cancer Research’s Rewards to Discoverer’s Scheme Patent (EP1933709B1), issued for a localization and stabilization device in Europe, Canada and India. D.D. receives honoraria from Janssen Pharmaceuticals. R.E. has the following conflicts of interest to declare: Honoraria from GU-ASCO, Janssen, University of Chicago, Dana Farber Cancer Institute USA as a speaker. Educational honorarium from Bayer and Ipsen, member of external expert committee to Astra Zeneca UK and Member of Active Surveillance Movember Committee. She is a member of the SAB of Our Future Health. She undertakes private practice as a sole trader at The Royal Marsden NHS Foundation Trust and 90 Sloane Street SW1X 9PQ and 280 Kings Road SW3 4NX, London, UK. The other authors declare no competing interests.